Investors - Publish Your Stock
Picks and Stock Profiles
at Investorideas.com
Share your investor ideas!
Publish here today!
Investors Get 10 Stock Directories & Investor Newsletter for
just $99 Year!
Become a Member
Featured Nanotechnology Stocks ADVERTISEMENT
Featured Sponsors - To request more info on any of our featured
companies click here
*If you are interested in becoming a featured company for this portal please contact
dvanzant@investorideas.com for a proposal.
Featured Science & Technology Content
What are the analysts saying?
3M Co. (MMM) 3M Company operates as a diversified technology company. It operates in six segments: Consumer and Office; Display and Graphics; Electronics and Telecommunications; Safety, Security, and Protection Services; Health Care; Industrial and Transportation. Consumer and Office segment offers office supply and stationery products, construction and home improvement products, protective material products, and visual systems products to education, home improvement and maintenance, and food service markets. Display and Graphics segment provides optical film and lens solutions for electronic displays; touch screens and touch monitors; reflective sheeting; and commercial graphics systems serving electronic display, touch screen, traffic safety, and commercial graphics markets. Electro and Communications segment offers electronic and interconnect solutions, micro interconnect systems, telecommunications products, and electrical products serving electrical, electronics, and communications industries. Safety, Security, and Protection segment offers personal protection products, safety and security products, energy control products, cleaning and protection products, and roofing granules for asphalt shingles. Health Care segment offers medical and surgical supplies, pharmaceuticals, drug delivery systems, dental and orthodontic products, health information systems, and microbiology products. Industrial and Transportation segment offers tapes, coated and nonwoven abrasives, adhesives, and supply chain execution software solutions to electronics, paper, packaging, and food and beverage markets, as well as components and products used in the manufacture, repair, and maintenance of automotive, marine, aircraft, and other vehicles. The company sells its products directly, as well as through wholesalers, retailers, jobbers, distributors, and dealers worldwide.
Abraxis Bioscience (Nasdaq: ABII) Abraxis BioScience, Inc. is an integrated global biopharmaceutical company dedicated to meeting the needs of critically ill patients. The company develops, manufactures and markets one of the broadest portfolios of injectable products and leverages revolutionary technology such as its nab(TM) platform to discover and deliver breakthrough therapeutics that transform the treatment of cancer and other life-threatening diseases. The first FDA approved product to use this nab platform, ABRAXANE®, was launched in 2005 for the treatment of metastatic breast cancer.
Acacia Research Corp. - Combimatrix (ACTG) - Acacia Research Corporation comprises two operating groups: Acacia Technologies Group and CombiMatrix Group. The CombiMatrix group is developing a platform technology to rapidly produce customizable arrays, which are semiconductor-based tools for use in identifying and determining the roles of genes, gene mutations and proteins. The CombiMatrix's group's technology has a wide range of potential applications in the areas of genomics, proteomics, biosensors, drug discovery, drug development, diagnostics, combinatorial chemistry, material sciences and nanotechnology. The Acacia Technologies group develops, acquires, and licenses patented technologies. Acacia controls 33 patent portfolios, which include over 120 U.S. patents, and certain foreign counterparts, covering technologies used in a wide variety of industries including audio/video enhancement & synchronization, broadcast data retrieval, computer memory cache coherency, credit card fraud protection, database management, data encryption & product activation, digital media transmission (DMT®), digital video production, dynamic manufacturing modeling, enhanced Internet navigation, high resolution optics, image resolution enhancement, interactive data sharing, interactive television, hearing aid ECS, interstitial Internet advertising, laptop docking station connectivity, microprocessor enhancement, multi-dimensional bar codes, network data storage, resource scheduling, rotational video imaging and spreadsheet automation. Acacia Research-Acacia Technologies (Nasdaq: ACTG) and Acacia Research-CombiMatrix (Nasdaq:CBMX ) are both classes of common stock issued by Acacia Research Corporation and are intended to reflect the performance of the respective operating groups and are not issued by the operating groups.
Accelrys (ACCL) develops and commercializes scientific business intelligence software for the integration, mining, analysis, modeling and simulation, management and interactive reporting of scientific data. Accelrys solutions support nanotechnology researchers in areas such as multiscale modeling, analytical instrument simulation and data processing, as well as image analysis and processing.
Acrongenomics, Inc. (AGNM.OB) is a Research & Development nanobiotechnology company pioneering the development of uniquely advanced nanomolecular diagnostics for the Life Sciences Industry. The Company seeks to establish its proprietary nanotechnology platform as a standard in Molecular In Vitro Diagnostics. Acrongenomics is dedicated to transforming scientific concepts into reality, as it has successfully applied Nanotechnology inspirations into next-generation Biotechnology applications.
Actelion Ltd (ALIOF.PK) ( Switzerland) Actelion Ltd. is a biopharmaceutical company with its corporate headquarters in Allschwil/Basel, Switzerland. Actelion's first drug Tracleer(r), an orally available dual endothelin receptor antagonist, has been approved as a therapy for pulmonary arterial hypertension. Actelion markets Tracleer(r) through its own subsidiaries in key markets worldwide, including the United States (based in South San Francisco), the European Union, Japan, Canada, Australia and Switzerland. At the end of September 2006, Tracleer(r) was commercially available in 35 countries worldwide. Actelion, founded in late 1997, is a leading player in innovative science related to the endothelium - the single layer of cells separating every blood vessel from the blood stream. Actelion's over 1,200 employees focus on the discovery, development and marketing of innovative drugs for significant unmet medical needs. Actelion shares are traded on the SWX Swiss Exchange (ticker symbol:ATLN)
Acusphere Inc. (ACUS) Acusphere, Inc., a specialty pharmaceutical company, develops new drugs and formulations of existing drugs using its proprietary porous microparticle technology in the United States. Its porous microparticle technology enables to control the size and porosity of particles, including nanoparticles and microparticles. The company primarily develops products in the areas of cardiology, oncology, and asthma. Its products include AI-700, an ultrasound contrast agent, which is in Phase III clinical development for the detection of coronary heart disease; AI-850, a Phase I clinical trial completed product that utilizes hydrophobic drug delivery system to improve the dissolution rate of a cancer drug; AI-128, a Phase I clinical study completed formulation of asthma drug. The company has strategic collaboration with Nycomed Danmark ApS.
Advance Nanotech, Inc. (AVNA: OB) ("Advance") commercializes innovative nanotechnology. Operating in three areas, electronics, biopharma and materials, Advance leverages relationships with financial and development resources to enable a product focused fast-track commercialization of nanotechnology. Advance has established relationships with academic institutions throughout the world that are at the forefront of nanotechnology research and development. Advance's objective is to invest in patented innovation to bridge early stage product development with valuable markets.
Advectus Life SCI (AVXSF.PK)
A development stage company focused on the development and commercialization of a patented process using nanotechnology for the delivery of approved cancer fighting drugs across the blood-brain barrier for the treatment of brain tumors.
Aixtron AG Aachen SH (AIXG) AIXTRON AG is a leading provider of deposition equipment to the semiconductor industry. The Company's technology solutions are used by a diverse range of customers worldwide to build advanced components for electronic and opto-electronic applications based on compound, silicon, or organic semiconductor materials. Such components are used in fiber optic communication systems, wireless and mobile telephony applications, optical and electronic storage devices, computing, signaling and lighting, as well as a range of other leading-edge technologies.
The Nanotechnology Stocks List is currently being updated for members. Check back soon!
Our site does not give specific recommendations and encourages investors to complete their own due diligence. Our lists are compiled from internal and external research sources. Our lists are to be used only as a partial source of due diligence.
*Stock directory compiled and copyright property of Investorideas.com
TOP
